SHANNON TIMMERMAN: Open Payments
NPI 1821605346 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,883 in 93 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $781 · 2025 $1,883
Food & beverage: $1,883
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $408 |
| Janssen Biotech, Inc. | 12 | $389 |
| ABBVIE INC. | 25 | $351 |
| Madrigal Pharmaceuticals | 6 | $246 |
| QOL Medical, LLC | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Ipsen Biopharmaceuticals, Inc | 4 | $80 |
| GENZYME CORPORATION | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Gilead Sciences, Inc. | 2 | $35 |
Products named: XIFAXAN, TREMFYA, REZDIFFRA, RINVOQ, DUPIXENT, Sucraid, LINZESS, IQIRVO.
Industry payments across GA — which companies pay providers there.
